From: Development of a prognostic model for 1-year survival after fragile hip fracture in Chinese
Characteristic | Patients with an outcome (n = 68) | Patients without an outcome (n = 667) | Univariate hazard ratios (95% CI) | Full model hazard ratios(95%CI) | LASSO model hazard ratios(95%CI) |
---|---|---|---|---|---|
Demographic characteristics | |||||
Age (years) (82 vs. 68) | 80 (SD 7.9) | 74 (SD 9.5) | 2.7 (1.8, 4.0) | 2.2 (1.4, 3.5) | 1.8 (1.2, 2.8) |
Sex (Female = 0, Male = 1, 1 vs. 0) | 35 (51.5%) (Male) | 244 (36.6%) (Male) | 1.7 (1.1, 2.8) | 1.7 (1.0, 2.8) | 1.4 (0.8, 2.2) |
Medical history | |||||
MLA (No = 0, Yes = 1, 1 vs. 0) | 5 (7.4%) (Yes) | 13 (1.9%) (Yes) | 3.2 (1.3, 7.9) | 4.1 (1.4, 11.9) | 2.7 (1.0, 7.7) |
LD (No = 0, Yes = 1, 1 vs. 0) | 34 (50.0%) (Yes) | 266 (39.9%) (Yes) | 1.5 (1.0, 2.5) | 1.0 (0.6, 1.7) | - |
ALI (No = 0, Yes = 1, 0 vs. 1) | 15 (22.1%) (No) | 92 (13.8%) (No) | 1.7 (0.9, 3.0) | 1.5 (0.8, 2.9) | 1.3 (0.7, 2.5) |
CCD (No = 0, Yes = 1, 1 vs. 0) | 37 (54.4%) (Yes) | 258 (38.7%) (Yes) | 1.8 (1.1, 3.0) | 1.5 (0.9, 2.6) | 1.4 (0.8, 2.4) |
HYP (No = 0, Yes = 1, 1 vs. 0) | 34 (50.0%) (Yes) | 323 (48.4%) (Yes) | 1.1 (0.7, 1.7) | 1.5 (0.8, 2.5) | 1.2 (0.7, 2.0) |
Clinical indicators | |||||
BS (mmol/L) (7.1 vs. 5.5) | 6.9 (SD 2.7) | 6.8 (SD 2.3) | 1.0 (0.9, 1.2) | 1.1 (0.9, 1.2) | – |
SC (μmol/L) (79 vs. 56) | 80.1 (SD 32.2) | 69.2 (SD 22.5) | 1.3 (1.1, 1.6) | 1.2 (1.0, 1.5) | 1.2 (1.0, 1.4) |
ALB(g/L) (40.8 vs. 35.3) | 35.1 (SD 4.3) | 38.1 (SD 4.0) | 0.4 (0.3, 0.6) | 0.6 (0.4, 0.8) | 0.6 (0.5, 0.9) |
Hb(g/L) (132 vs. 104) | 111.2 (SD 23.3) | 118.4 (SD 19.6) | 0.6 (0.5, 0.9) | 1.1 (0.7, 1.5) | – |
Treatment | |||||
SUR (No = 0, Yes = 1, 0 vs. 1) | 30 (44.1%) (No) | 59 (8.8%) (No) | 6.9 (4.3, 11.2) | 5.2 (3.1, 8.7) | 4.8 (2.9, 8.0) |